ORIGINAL RESEARCH
Published on 01 Jul 2026
Pemafibrate is associated with greater reductions in MDA-LDL and small dense LDL fractions with exploratory PBMC gene-expression changes: a prespecified subanalysis of the PARADISE in Kagoshima study
doi 10.3389/fcdhc.2026.1850470
- 704 views
